Skip to main content

Table 1 Baseline Characteristics of Patients and Home Nebulizers

From: Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations

Data regarding patients/ home nebulizers

Mean ± SD or n (%)

Total = 61

Age (years)

7.6 ± 4.2

Weight (Kg)

23.6 ± 13.3

Height / length (cm)

121.3 ± 25.3

Male gender (%)

35 (57.4%)

Type of home nebulizers (%)

 Jet

39 (63.9%)

 Ultrasonic

16 (26.2%)

 Mesh

6 (9.8%)

Duration of use (years)

3.6 ± 2.9

Replace nebulizer parts

 None

48 (78.5%)

 Mask/mouthpiece

6 (10%)

 Reservoir

4 (6.5%)

 Connecting tube

3 (5%)

Number of daily inhalation

 All devices

2.6 ± 0.7

 Contaminated devices

2.7 ± 0.7

 Clean devices

2.3 ± 0.8

Inhaled antibiotics (%)

 None

23 (37.7%)

 Gentamicin

18 (29.5%)

 Amikacin

10 (16.4%)

 Tobramycin

2 (3.3%)

 Vancomycin

8 (13.1%)